Celcuity Inc. (CELC)
NASDAQ·Healthcare·Biotechnology
$120.88
-4.02%
Mkt Cap $5.92B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | $1.27M | — | — | -$1.06 | -$0.97 | +8.49% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$1.02 | -$0.92 | +9.80% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.90 | -$1.04 | -15.56% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.95 | -$0.86 | +9.47% | — | — |
| Q1 2025 Mar 31, 2025 | — | $121.34K | — | -$0.72 | -$0.85 | -18.06% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.65 | -$0.70 | -7.69% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.71 | -$0.62 | +12.68% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$0.71 | -$0.64 | +9.86% | — | — |
| Q1 2024 Mar 27, 2024 | — | $229.65K | — | -$0.71 | -$0.65 | +8.45% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.74 | -$0.83 | -12.16% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.67 | -$0.66 | +1.49% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.65 | -$0.55 | +15.38% | — | — |
| Q1 2023 Mar 23, 2023 | — | — | — | -$0.54 | -$0.69 | -27.78% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.49 | -$0.75 | -53.06% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.47 | -$0.67 | -42.55% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$0.51 | -$0.53 | -3.92% | — | — |
| Q1 2022 Mar 23, 2022 | — | — | — | -$0.40 | -$0.45 | -12.50% | — | — |
| Q4 2021 Nov 8, 2021 | — | — | — | -$0.35 | -$0.41 | -17.14% | — | — |
| Q3 2021 Aug 9, 2021 | — | — | — | -$0.38 | -$1.11 | -192.11% | — | — |
| Q2 2021 May 10, 2021 | — | — | — | -$0.20 | -$0.25 | -25.00% | — | — |